Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS research M Sanni Ali received a Young Investigator Award at this week’s National Osteoporosis Society Conference 2016, held in Birmingham.

Sanni presented work on a non-experimental study using SIDIAP, a real life database from Catalonia, North East Spain. The Prieto-Alhambra Group - Musculoskeletal Pharmaco- and Device epidemiology - at NDORMS evaluated the comparative risk of fragility fracture in type 2 diabetic patients using different anti-diabetic medications.

It is estimated that 415 million people between the ages of 20 and 70 worldwide have diabetes, with the condition expected to affect one person in 10 by 2040 - 642 million. In addition, it is estimated globally that 1 in 2 adults with Type 2 diabetes are undiagnosed.

Sanni said: "We found that the risk of fragility fracture is higher in insulin users compared to patients who are on metformin mono-therapy. This data is very useful to manage the condition in the broader context of a patient's life and hopefully can inform new therapeutic approaches for these patients."

Together with another abstract, Sanni's submitted work to the conference received the highest score from reviewers.

Speaking on the award, Sanni said: "This is a unique conference and I was honoured to meet the world's most influential scientists in the field of osteoporosis. Having my research recognised in such a setting was wonderful and I would like to thank the reviewers and my team for the opportunity."

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.